Chris Buckley

Chris Buckley

General Electric Company - Boston / United States
Medical and Health Sciences / Neurology
AD Scientific Index ID: 4377811
-
person_outline Chris Buckley's MOST POPULAR ARTICLES
1-) 18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trialR Vandenberghe, K Van Laere, A Ivanoiu, E Salmon, C Bastin, E Triau, ...Annals of neurology 68 (3), 319-329, 20106562010
2-) Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image readsL Thurfjell, J Lilja, R Lundqvist, C Buckley, A Smith, R Vandenberghe, ...Journal of Nuclear Medicine 55 (10), 1623-1628, 20141762014
3-) Association between in vivo fluorine 18–labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathologyDA Wolk, ID Grachev, C Buckley, H Kazi, MS Grady, JQ Trojanowski, ...Archives of neurology 68 (11), 1398-1403, 20111752011
4-) Flutriciclamide (18F-GE180) PET: first-in-human PET study of novel third-generation in vivo marker of human translocator proteinZ Fan, V Calsolaro, RA Atkinson, GD Femminella, A Waldman, C Buckley, ...Journal of Nuclear Medicine 57 (11), 1753-1759, 20161232016
5-) Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injectionMD Ikonomovic, CJ Buckley, K Heurling, P Sherwin, PA Jones, M Zanette, ...Acta neuropathologica communications 4, 1-24, 20161062016